Cargando…

A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma

Background: Basement membranes (BMs) are associated with cell polarity, differentiation, migration, and survival. Previous studies have shown that BMs play a key role in the progression of cancer, and thus could serve as potential targets for inhibiting the development of cancer. However, the associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Tao, Chen, Weikang, Wu, Zhigang, Cai, Jian, Zhou, Chaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520985/
https://www.ncbi.nlm.nih.gov/pubmed/36186476
http://dx.doi.org/10.3389/fgene.2022.994208
_version_ 1784799747048996864
author Zhou, Tao
Chen, Weikang
Wu, Zhigang
Cai, Jian
Zhou, Chaofeng
author_facet Zhou, Tao
Chen, Weikang
Wu, Zhigang
Cai, Jian
Zhou, Chaofeng
author_sort Zhou, Tao
collection PubMed
description Background: Basement membranes (BMs) are associated with cell polarity, differentiation, migration, and survival. Previous studies have shown that BMs play a key role in the progression of cancer, and thus could serve as potential targets for inhibiting the development of cancer. However, the association between basement membrane-related genes (BMRGs) and clear cell renal cell carcinoma (ccRCC) remains unclear. To address that gap, we constructed a novel risk signature utilizing BMRGs to explore the relationship between ccRCC and BMs. Methods: We gathered transcriptome and clinical data from The Cancer Genome Atlas (TCGA) and randomly separated the data into training and test sets to look for new potential biomarkers and create a predictive signature of BMRGs for ccRCC. We applied univariate, least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses to establish the model. The risk signature was further verified and evaluated through principal component analysis (PCA), the Kaplan-Meier technique, and time-dependent receiver operating characteristics (ROC). A nomogram was constructed to predict the overall survival (OS). The possible biological pathways were investigated through functional enrichment analysis. In this study, we also determined tumor mutation burden (TMB) and performed immunological analysis and immunotherapeutic drug analysis between the high- and low-risk groups. Results: We identified 33 differentially expressed genes and constructed a risk model of eight BMRGs, including COL4A4, FREM1, CSPG4, COL4A5, ITGB6, ADAMTS14, MMP17, and THBS4. The PCA analysis showed that the signature could distinguish the high- and low-risk groups well. The K-M and ROC analysis demonstrated that the model could predict the prognosis well from the areas under the curves (AUCs), which was 0.731. Moreover, the nomogram showed good predictability. Univariate and multivariate Cox regression analysis validated that the model results supported the hypothesis that BMRGs were independent risk factors for ccRCC. Furthermore, immune cell infiltration, immunological checkpoints, TMB, and the half-inhibitory concentration varied considerably between high- and low-risk groups. Conclusion: Employing eight BMRGs to construct a risk model as a prognostic indicator of ccRCC could provide us with a potential progression trajectory as well as predictions of therapeutic response.
format Online
Article
Text
id pubmed-9520985
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95209852022-09-30 A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma Zhou, Tao Chen, Weikang Wu, Zhigang Cai, Jian Zhou, Chaofeng Front Genet Genetics Background: Basement membranes (BMs) are associated with cell polarity, differentiation, migration, and survival. Previous studies have shown that BMs play a key role in the progression of cancer, and thus could serve as potential targets for inhibiting the development of cancer. However, the association between basement membrane-related genes (BMRGs) and clear cell renal cell carcinoma (ccRCC) remains unclear. To address that gap, we constructed a novel risk signature utilizing BMRGs to explore the relationship between ccRCC and BMs. Methods: We gathered transcriptome and clinical data from The Cancer Genome Atlas (TCGA) and randomly separated the data into training and test sets to look for new potential biomarkers and create a predictive signature of BMRGs for ccRCC. We applied univariate, least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analyses to establish the model. The risk signature was further verified and evaluated through principal component analysis (PCA), the Kaplan-Meier technique, and time-dependent receiver operating characteristics (ROC). A nomogram was constructed to predict the overall survival (OS). The possible biological pathways were investigated through functional enrichment analysis. In this study, we also determined tumor mutation burden (TMB) and performed immunological analysis and immunotherapeutic drug analysis between the high- and low-risk groups. Results: We identified 33 differentially expressed genes and constructed a risk model of eight BMRGs, including COL4A4, FREM1, CSPG4, COL4A5, ITGB6, ADAMTS14, MMP17, and THBS4. The PCA analysis showed that the signature could distinguish the high- and low-risk groups well. The K-M and ROC analysis demonstrated that the model could predict the prognosis well from the areas under the curves (AUCs), which was 0.731. Moreover, the nomogram showed good predictability. Univariate and multivariate Cox regression analysis validated that the model results supported the hypothesis that BMRGs were independent risk factors for ccRCC. Furthermore, immune cell infiltration, immunological checkpoints, TMB, and the half-inhibitory concentration varied considerably between high- and low-risk groups. Conclusion: Employing eight BMRGs to construct a risk model as a prognostic indicator of ccRCC could provide us with a potential progression trajectory as well as predictions of therapeutic response. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520985/ /pubmed/36186476 http://dx.doi.org/10.3389/fgene.2022.994208 Text en Copyright © 2022 Zhou, Chen, Wu, Cai and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Zhou, Tao
Chen, Weikang
Wu, Zhigang
Cai, Jian
Zhou, Chaofeng
A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title_full A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title_fullStr A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title_full_unstemmed A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title_short A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
title_sort newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520985/
https://www.ncbi.nlm.nih.gov/pubmed/36186476
http://dx.doi.org/10.3389/fgene.2022.994208
work_keys_str_mv AT zhoutao anewlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT chenweikang anewlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT wuzhigang anewlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT caijian anewlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT zhouchaofeng anewlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT zhoutao newlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT chenweikang newlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT wuzhigang newlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT caijian newlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma
AT zhouchaofeng newlydefinedbasementmembranerelatedgenesignaturefortheprognosisofclearcellrenalcellcarcinoma